Olga Surova

749 total citations
17 papers, 564 citations indexed

About

Olga Surova is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Olga Surova has authored 17 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Olga Surova's work include Cell death mechanisms and regulation (5 papers), MicroRNA in disease regulation (3 papers) and Mitochondrial Function and Pathology (2 papers). Olga Surova is often cited by papers focused on Cell death mechanisms and regulation (5 papers), MicroRNA in disease regulation (3 papers) and Mitochondrial Function and Pathology (2 papers). Olga Surova collaborates with scholars based in Sweden, Ukraine and United States. Olga Surova's co-authors include Boris Zhivotovsky, Vitaliy O. Kaminskyy, Alena Hyršlová Vaculová, Susanne Schlisio, Shuijie Li, Per Kogner, Johan Holmberg, I. B. Zborovskaya, Elena M. Tchevkina and Victor Dosenko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and PLoS ONE.

In The Last Decade

Olga Surova

17 papers receiving 558 citations

Peers

Olga Surova
Fabiola Sesti Italy
Anping Song China
Yan Long United States
Hubert Kasperczyk Germany
Xinghua Yuan China
Muhammad Tufail China
Lindsey N. Jackson United States
Mingsong Wang China
Sylvain Peuget Sweden
Fabiola Sesti Italy
Olga Surova
Citations per year, relative to Olga Surova Olga Surova (= 1×) peers Fabiola Sesti

Countries citing papers authored by Olga Surova

Since Specialization
Citations

This map shows the geographic impact of Olga Surova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Surova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Surova more than expected).

Fields of papers citing papers by Olga Surova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Surova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Surova. The network helps show where Olga Surova may publish in the future.

Co-authorship network of co-authors of Olga Surova

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Surova. A scholar is included among the top collaborators of Olga Surova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Surova. Olga Surova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Liang, Ying, Olga Surova, Silviu‐Alin Bacanu, et al.. (2024). Proteome-wide CETSA reveals diverse apoptosis-inducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery. Cell Reports. 43(10). 114784–114784. 2 indexed citations
3.
Gruber, Michael, Elisabeth Pritz, Armin Gerger, et al.. (2023). Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse. Journal of Translational Medicine. 21(1). 528–528. 3 indexed citations
4.
Li, Shuijie, Javier Rodríguez, Wenyu Li, et al.. (2019). EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance. Proceedings of the National Academy of Sciences. 116(34). 16997–17006. 12 indexed citations
5.
Lebraud, Honorine, Olga Surova, Aurélie Courtin, et al.. (2018). Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe. Chemical Science. 9(45). 8608–8618. 10 indexed citations
6.
Li, Shuijie, Karin Wallis, Anna Kock, et al.. (2017). Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA. Genes & Development. 31(10). 1036–1053. 14 indexed citations
7.
Westerlund, Isabelle, Shi Yao, Shuijie Li, et al.. (2017). Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression. Proceedings of the National Academy of Sciences. 114(30). E6137–E6146. 47 indexed citations
8.
Li, Shuijie, Olga Surova, Erik Smedler, et al.. (2016). The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis. Developmental Cell. 36(2). 164–178. 25 indexed citations
9.
Surova, Olga, Giulia Allavena, Katarína Gyurászová, et al.. (2015). Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11. Oncotarget. 6(14). 12156–12173. 28 indexed citations
10.
Kaminskyy, Vitaliy O., Olga Surova, Tatiana S. Piskunova, et al.. (2013). Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling. Cell Death and Disease. 4(3). e522–e522. 20 indexed citations
11.
12.
Surova, Olga & Boris Zhivotovsky. (2012). Various modes of cell death induced by DNA damage. Oncogene. 32(33). 3789–3797. 256 indexed citations
13.
Dosenko, Victor, et al.. (2012). Mature and immature microRNA ratios in cultured rat cardiomyocytes during anoxia-reoxygenation.. PubMed. 17(2). 84–7. 6 indexed citations
14.
Kaminskyy, Vitaliy O., Olga Surova, Alena Hyršlová Vaculová, & Boris Zhivotovsky. (2011). Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. Carcinogenesis. 32(10). 1450–1458. 63 indexed citations
15.
Vaculová, Alena Hyršlová, et al.. (2010). Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL. Molecular Cancer. 9(1). 87–87. 35 indexed citations
16.
Surova, Olga, et al.. (2009). Effect of a low dose of proteasome inhibitor on cell death and gene expression in neonatal rat cardiomyocyte cultures exposed to anoxia-reoxygenation.. PubMed. 14(2). e57–61. 6 indexed citations
17.
Dosenko, Victor, et al.. (2009). Cardioprotective effect of 5-lipoxygenase gene (ALOX5) silencing in ischemia-reperfusion.. Acta Biochimica Polonica. 56(4). 687–94. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiola Sesti Breakdown of academic impact, for papers by Anping Song Breakdown of academic impact, for papers by Yan Long Breakdown of academic impact, for papers by Hubert Kasperczyk Breakdown of academic impact, for papers by Xinghua Yuan Breakdown of academic impact, for papers by Muhammad Tufail Breakdown of academic impact, for papers by Lindsey N. Jackson Breakdown of academic impact, for papers by Mingsong Wang Breakdown of academic impact, for papers by Sylvain Peuget
Rankless by CCL
2026